Lothar Haeberle

5PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical Trial.

|Jul 11, 2025
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.

Milena Beierlein, Lothar Häberle, Naiba Nabieva

|Sep 02, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.

Theophilos Tzaridis, Johannes Weller, Daniel Bachurski

|Mar 23, 2019
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.

Naiba Nabieva, Lothar Häberle, Sara Y Brucker

|May 03, 2017
Correlation of mammographic density and serum calcium levels in patients with primary breast cancer.

Carolin C Hack, Martin J Stoll, Sebastian M Jud

Pageof 1

Frequent Collaborators

3 joint publications

Peter A Fasching

2 joint publications

Paul Gass

2 joint publications

Chloë Goossens

1 joint publications

Naiba Nabieva